Abeona Therapeutics Stock Price History
ABEO Stock | USD 5.14 0.06 1.15% |
Below is the normalized historical share price chart for Abeona Therapeutics extending back to November 05, 1984. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Abeona Therapeutics stands at 5.14, as last reported on the 21st of March, with the highest price reaching 5.14 and the lowest price hitting 5.14 during the day.
If you're considering investing in Abeona Stock, it is important to understand the factors that can impact its price. Abeona Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0427, which signifies that the company had a -0.0427 % return per unit of standard deviation over the last 3 months. Abeona Therapeutics exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Abeona Therapeutics' risk adjusted performance of (0.05), and Mean Deviation of 1.93 to double-check the risk estimate we provide.
At this time, Abeona Therapeutics' Issuance Of Capital Stock is very stable compared to the past year. . At this time, Abeona Therapeutics' Price Book Value Ratio is very stable compared to the past year. As of the 21st of March 2025, Price Earnings To Growth Ratio is likely to grow to 0.40, while Price To Sales Ratio is likely to drop 33.44. Abeona Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 19th of September 1980 | 200 Day MA 5.5111 | 50 Day MA 5.484 | Beta 1.782 |
Abeona |
Sharpe Ratio = -0.0427
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | ABEO |
Estimated Market Risk
3.0 actual daily | 26 74% of assets are more volatile |
Expected Return
-0.13 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.04 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Abeona Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Abeona Therapeutics by adding Abeona Therapeutics to a well-diversified portfolio.
Price Book 4.9385 | Enterprise Value Ebitda (0.58) | Price Sales 61.6302 | Shares Float 29.1 M | Wall Street Target Price 15.9167 |
Abeona Therapeutics Stock Price History Chart
There are several ways to analyze Abeona Stock price data. The simplest method is using a basic Abeona candlestick price chart, which shows Abeona Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | January 3, 2025 | 6.02 |
Lowest Price | March 10, 2025 | 5.04 |
Abeona Therapeutics March 21, 2025 Stock Price Synopsis
Various analyses of Abeona Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Abeona Stock. It can be used to describe the percentage change in the price of Abeona Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Abeona Stock.Abeona Therapeutics Price Action Indicator | (0.03) | |
Abeona Therapeutics Price Rate Of Daily Change | 0.99 |
Abeona Therapeutics March 21, 2025 Stock Price Analysis
Abeona Stock Price History Data
The price series of Abeona Therapeutics for the period between Sat, Dec 21, 2024 and Fri, Mar 21, 2025 has a statistical range of 0.98 with a coefficient of variation of 5.45. The prices are distributed with arithmetic mean of 5.55. The median price for the last 90 days is 5.59. The company had 1:25 stock split on 5th of July 2022.Open | High | Low | Close | Volume | ||
03/21/2025 | 5.20 | 5.14 | 5.14 | 5.14 | ||
03/20/2025 | 5.20 | 5.41 | 4.95 | 5.14 | 1,272,365 | |
03/19/2025 | 5.23 | 5.24 | 5.08 | 5.20 | 246,613 | |
03/18/2025 | 5.23 | 5.35 | 5.11 | 5.16 | 336,485 | |
03/17/2025 | 5.29 | 5.40 | 5.19 | 5.30 | 241,265 | |
03/14/2025 | 5.30 | 5.45 | 5.28 | 5.29 | 287,738 | |
03/13/2025 | 5.56 | 5.60 | 5.26 | 5.28 | 277,242 | |
03/12/2025 | 5.52 | 5.60 | 5.40 | 5.59 | 313,501 | |
03/11/2025 | 5.04 | 5.49 | 5.03 | 5.46 | 484,574 | |
03/10/2025 | 5.11 | 5.17 | 4.92 | 5.04 | 406,786 | |
03/07/2025 | 5.32 | 5.45 | 5.08 | 5.16 | 560,707 | |
03/06/2025 | 5.19 | 5.40 | 5.02 | 5.30 | 454,534 | |
03/05/2025 | 5.33 | 5.58 | 5.15 | 5.26 | 625,448 | |
03/04/2025 | 5.07 | 5.20 | 4.91 | 5.07 | 387,439 | |
03/03/2025 | 5.26 | 5.35 | 5.09 | 5.09 | 218,148 | |
02/28/2025 | 5.11 | 5.26 | 5.06 | 5.24 | 181,573 | |
02/27/2025 | 5.25 | 5.43 | 5.13 | 5.14 | 209,137 | |
02/26/2025 | 5.32 | 5.38 | 5.19 | 5.26 | 279,253 | |
02/25/2025 | 5.50 | 5.68 | 5.20 | 5.33 | 428,100 | |
02/24/2025 | 5.78 | 5.82 | 5.49 | 5.50 | 323,530 | |
02/21/2025 | 5.86 | 5.91 | 5.76 | 5.78 | 168,590 | |
02/20/2025 | 5.86 | 5.92 | 5.79 | 5.82 | 180,085 | |
02/19/2025 | 5.83 | 5.94 | 5.81 | 5.86 | 144,886 | |
02/18/2025 | 6.00 | 6.10 | 5.79 | 5.85 | 358,329 | |
02/14/2025 | 5.92 | 6.16 | 5.91 | 6.02 | 352,888 | |
02/13/2025 | 6.02 | 6.05 | 5.86 | 5.93 | 339,307 | |
02/12/2025 | 5.58 | 6.04 | 5.58 | 6.00 | 371,526 | |
02/11/2025 | 5.82 | 5.82 | 5.63 | 5.65 | 185,518 | |
02/10/2025 | 5.70 | 5.84 | 5.65 | 5.82 | 156,819 | |
02/07/2025 | 5.85 | 5.93 | 5.67 | 5.70 | 284,490 | |
02/06/2025 | 5.95 | 6.06 | 5.83 | 5.88 | 266,672 | |
02/05/2025 | 5.89 | 6.06 | 5.85 | 5.88 | 238,034 | |
02/04/2025 | 5.50 | 5.87 | 5.50 | 5.86 | 352,451 | |
02/03/2025 | 5.41 | 5.57 | 5.40 | 5.50 | 217,640 | |
01/31/2025 | 5.47 | 5.68 | 5.47 | 5.54 | 237,491 | |
01/30/2025 | 5.50 | 5.64 | 5.44 | 5.47 | 205,229 | |
01/29/2025 | 5.41 | 5.48 | 5.35 | 5.45 | 178,742 | |
01/28/2025 | 5.31 | 5.51 | 5.22 | 5.41 | 316,583 | |
01/27/2025 | 5.24 | 5.70 | 5.24 | 5.30 | 477,608 | |
01/24/2025 | 5.24 | 5.35 | 5.17 | 5.26 | 405,552 | |
01/23/2025 | 5.10 | 5.28 | 5.10 | 5.25 | 278,069 | |
01/22/2025 | 5.18 | 5.18 | 5.06 | 5.14 | 185,524 | |
01/21/2025 | 5.22 | 5.27 | 5.05 | 5.19 | 406,442 | |
01/17/2025 | 5.27 | 5.32 | 5.21 | 5.22 | 170,213 | |
01/16/2025 | 5.30 | 5.32 | 5.17 | 5.24 | 183,826 | |
01/15/2025 | 5.27 | 5.43 | 5.10 | 5.30 | 375,899 | |
01/14/2025 | 5.66 | 5.66 | 5.05 | 5.09 | 676,389 | |
01/13/2025 | 5.48 | 5.64 | 5.31 | 5.61 | 267,133 | |
01/10/2025 | 5.88 | 5.96 | 5.48 | 5.55 | 361,769 | |
01/08/2025 | 6.02 | 6.02 | 5.79 | 5.96 | 176,742 | |
01/07/2025 | 6.00 | 6.11 | 5.93 | 6.00 | 155,303 | |
01/06/2025 | 6.02 | 6.06 | 5.91 | 6.00 | 312,428 | |
01/03/2025 | 5.91 | 6.07 | 5.86 | 6.02 | 292,903 | |
01/02/2025 | 5.61 | 6.00 | 5.60 | 5.91 | 392,956 | |
12/31/2024 | 5.64 | 5.67 | 5.51 | 5.57 | 203,401 | |
12/30/2024 | 5.56 | 5.67 | 5.49 | 5.61 | 217,624 | |
12/27/2024 | 5.68 | 5.73 | 5.57 | 5.63 | 121,971 | |
12/26/2024 | 5.63 | 5.73 | 5.59 | 5.72 | 128,864 | |
12/24/2024 | 5.70 | 5.71 | 5.62 | 5.68 | 70,352 | |
12/23/2024 | 5.68 | 5.72 | 5.57 | 5.69 | 163,104 | |
12/20/2024 | 5.64 | 5.79 | 5.56 | 5.70 | 210,374 |
About Abeona Therapeutics Stock history
Abeona Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Abeona is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Abeona Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Abeona Therapeutics stock prices may prove useful in developing a viable investing in Abeona Therapeutics
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 24.6 M | 25.8 M | |
Net Loss | -39.1 M | -41.1 M |
Abeona Therapeutics Quarterly Net Working Capital |
|
Abeona Therapeutics Stock Technical Analysis
Abeona Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Analyst Advice Now
Analyst AdviceAnalyst recommendations and target price estimates broken down by several categories |
All Next | Launch Module |
Abeona Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Abeona Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Abeona Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Abeona to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.05) | |||
Jensen Alpha | (0.14) | |||
Total Risk Alpha | 0.0555 | |||
Treynor Ratio | (0.29) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abeona Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. To learn how to invest in Abeona Stock, please use our How to Invest in Abeona Therapeutics guide.You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abeona Therapeutics. If investors know Abeona will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abeona Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Abeona Therapeutics is measured differently than its book value, which is the value of Abeona that is recorded on the company's balance sheet. Investors also form their own opinion of Abeona Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Abeona Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abeona Therapeutics' market value can be influenced by many factors that don't directly affect Abeona Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abeona Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Abeona Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abeona Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.